相关实验视频

Updated: May 7, 2025

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Published on: February 17, 2023

精确的无模板校正恢复了Tay-Sachs疾病中的基因功能,而重构是无效的

Joshua E Hung^1,2, Reid A Brewer^1,2, Lujaina Elbakr^1,2

¹Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G0A4, Canada.

Molecular therapy. Nucleic acids

|January 6, 2025

概括

在一个细胞模型中,CRISPR-Cas9基因编辑精确地纠正了常见的Tay-Sachs疾病突变c.1278insTATC. 这种精确的校正恢复了HexA酶的功能,为Tay-Sachs病提供了潜在的治疗策略.

科学领域:

遗传学和基因组学遗传学和基因组学
分子生物学分子生物学
生物技术是生物技术.

背景情况:

泰-萨克斯病是一种致命的神经退行性疾病,由HEXA基因突变引起.
c.1278insTATC突变,即4-bp重复,是Tay-Sachs病的常见原因,导致框架转移和HexA酶功能的丧失.

研究的目的:

研究CRISPR-Cas9基因编辑的治疗潜力,以纠正泰萨克斯病中的c.1278insTATC突变.
探索微同质介导端结合 (MMEJ) 在修复基因组微重复中CRISPR诱导的双链断裂中的作用.

主要方法:

在一个工程细胞模型中利用CRISPR-Cas9技术来准c.1278insTATC突变.
分析了Cas9内核酶活性后的修复结果,包括精确的纠正和内核形成.
在编辑序列的细胞中评估HexA酶活性.

主要成果:

在c.1278insTATC复制中心附近的裂纹自发地重建了大约14.7%频率的野生类型序列.
恢复野生类型序列导致恢复正常的细胞HexA活动.
旨在恢复未经精确校正的开放阅读框架的替代编辑策略没有产生显著的HexA功能.

结论:

精确纠正c.1278insTATC突变是观察到的唯一具有治疗意义的结果.
微同质介导端结合 (MMEJ) 被强调为一种潜在的无模板CRISPR-Cas9策略,用于对Tay-Sachs疾病的精确基因校正.

关键词:

通过CRISPR-Cas9进行治疗编辑.转基因二氧化碳 (GM2) 质化症六角形六角形是指六角形.MT:RNA/DNA编辑编辑与PAM相关的目标定位.泰·萨克斯病是泰·萨克斯病的一种疾病.框架纠正疗法是指框架纠正疗法.通过微同学介导的结合端连接.突变纠正突变纠正

更多相关视频

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...